Leading figures in the pharmaceutical industry such as the United States, the European Union, and Japan are all worried about raw materials. The United States is willing to use the Defense Production Act, the European Union has released a lengthy report to promote the return of raw materials, and the United Kingdom is directly subsidizing pharmaceutical companies with money. Why? It's not because China's raw materials are too strong, so strong that they are afraid.
Speaking of this, some people may think of the myth of Indian generic drugs, but don't forget that behind India, the "world pharmacy", there is also a huge support of Chinese raw materials. India imports billions of raw materials from China every year, and many key raw materials are almost 100% dependent on China. So if the supply of Chinese raw materials is cut off, Indian generic drugs will also have to cool down, and the entire global pharmaceutical chain will tremble.

Many people know that the pharmaceutical industry in Europe and America is excellent, but what they don't know is that raw materials are the key to getting stuck in the throat in the pharmaceutical industry. Without active pharmaceutical ingredients, any patented drugs or new drugs are just empty talk, and China is precisely the invisible hegemon in this field. China not only has an absolute advantage in bulk raw materials, but almost all the raw materials for commonly used drugs such as antibiotics and vitamins are made in China.
Although Europe and the United States invented these drugs first, China successfully achieved overtaking on the bend with its strong chemical capabilities and unremitting technological innovation. For example, penicillin was once as expensive as gold, but now China can not only make it itself, but also produce many and good ones.

E-mail:

admin@fidecare.com

Tel: 

+8610-60728908

Address:

Room A003-805, 2nd Floor, Building 5, Tuanli South District, Luoyi Subdistrict, Tongzhou District, Beijing China.